Global GABA Receptor Agonist Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global GABA Receptor Agonist Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for GABA Receptor Agonist Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for GABA Receptor Agonist Drug by Country/Region, 2017, 2022 & 2028

2.2 GABA Receptor Agonist Drug Segment by Type

2.2.1 Bamaluzole

2.2.2 Phenibut

2.2.3 Baclofen

2.2.4 Gaboxadol

2.2.5 Klonopin (clonazepam)

2.2.6 Tiagbine

2.3 GABA Receptor Agonist Drug Sales by Type

2.3.1 Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)

2.3.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global GABA Receptor Agonist Drug Sale Price by Type (2017-2022)

2.4 GABA Receptor Agonist Drug Segment by Application

2.4.1 Attention Deficit Hyperactivity Disorder (ADHD)

2.4.2 Psychiatric Disorders and Depression

2.4.3 Alzheimer

2.4.4 Epilepsy and Seizure

2.4.5 Anxiety and Sleep Disorders

2.4.6 Obesity and Alcoholism

2.5 GABA Receptor Agonist Drug Sales by Application

2.5.1 Global GABA Receptor Agonist Drug Sale Market Share by Application (2017-2022)

2.5.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global GABA Receptor Agonist Drug Sale Price by Application (2017-2022)

3 Global GABA Receptor Agonist Drug by Company

3.1 Global GABA Receptor Agonist Drug Breakdown Data by Company

3.1.1 Global GABA Receptor Agonist Drug Annual Sales by Company (2020-2022)

3.1.2 Global GABA Receptor Agonist Drug Sales Market Share by Company (2020-2022)

3.2 Global GABA Receptor Agonist Drug Annual Revenue by Company (2020-2022)

3.2.1 Global GABA Receptor Agonist Drug Revenue by Company (2020-2022)

3.2.2 Global GABA Receptor Agonist Drug Revenue Market Share by Company (2020-2022)

3.3 Global GABA Receptor Agonist Drug Sale Price by Company

3.4 Key Manufacturers GABA Receptor Agonist Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers GABA Receptor Agonist Drug Product Location Distribution

3.4.2 Players GABA Receptor Agonist Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for GABA Receptor Agonist Drug by Geographic Region

4.1 World Historic GABA Receptor Agonist Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global GABA Receptor Agonist Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global GABA Receptor Agonist Drug Annual Revenue by Geographic Region

4.2 World Historic GABA Receptor Agonist Drug Market Size by Country/Region (2017-2022)

4.2.1 Global GABA Receptor Agonist Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global GABA Receptor Agonist Drug Annual Revenue by Country/Region

4.3 Americas GABA Receptor Agonist Drug Sales Growth

4.4 APAC GABA Receptor Agonist Drug Sales Growth

4.5 Europe GABA Receptor Agonist Drug Sales Growth

4.6 Middle East & Africa GABA Receptor Agonist Drug Sales Growth

5 Americas

5.1 Americas GABA Receptor Agonist Drug Sales by Country

5.1.1 Americas GABA Receptor Agonist Drug Sales by Country (2017-2022)

5.1.2 Americas GABA Receptor Agonist Drug Revenue by Country (2017-2022)

5.2 Americas GABA Receptor Agonist Drug Sales by Type

5.3 Americas GABA Receptor Agonist Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC GABA Receptor Agonist Drug Sales by Region

6.1.1 APAC GABA Receptor Agonist Drug Sales by Region (2017-2022)

6.1.2 APAC GABA Receptor Agonist Drug Revenue by Region (2017-2022)

6.2 APAC GABA Receptor Agonist Drug Sales by Type

6.3 APAC GABA Receptor Agonist Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe GABA Receptor Agonist Drug by Country

7.1.1 Europe GABA Receptor Agonist Drug Sales by Country (2017-2022)

7.1.2 Europe GABA Receptor Agonist Drug Revenue by Country (2017-2022)

7.2 Europe GABA Receptor Agonist Drug Sales by Type

7.3 Europe GABA Receptor Agonist Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa GABA Receptor Agonist Drug by Country

8.1.1 Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa GABA Receptor Agonist Drug Sales by Type

8.3 Middle East & Africa GABA Receptor Agonist Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of GABA Receptor Agonist Drug

10.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug

10.4 Industry Chain Structure of GABA Receptor Agonist Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 GABA Receptor Agonist Drug Distributors

11.3 GABA Receptor Agonist Drug Customer

12 World Forecast Review for GABA Receptor Agonist Drug by Geographic Region

12.1 Global GABA Receptor Agonist Drug Market Size Forecast by Region

12.1.1 Global GABA Receptor Agonist Drug Forecast by Region (2023-2028)

12.1.2 Global GABA Receptor Agonist Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global GABA Receptor Agonist Drug Forecast by Type

12.7 Global GABA Receptor Agonist Drug Forecast by Application

13 Key Players Analysis

13.1 Advicenne

13.1.1 Advicenne Company Information

13.1.2 Advicenne GABA Receptor Agonist Drug Product Offered

13.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Advicenne Main Business Overview

13.1.5 Advicenne Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca GABA Receptor Agonist Drug Product Offered

13.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Athena Drug Delivery Solutions

13.3.1 Athena Drug Delivery Solutions Company Information

13.3.2 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Offered

13.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Athena Drug Delivery Solutions Main Business Overview

13.3.5 Athena Drug Delivery Solutions Latest Developments

13.4 Biocodex

13.4.1 Biocodex Company Information

13.4.2 Biocodex GABA Receptor Agonist Drug Product Offered

13.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biocodex Main Business Overview

13.4.5 Biocodex Latest Developments

13.5 Elan Corporation

13.5.1 Elan Corporation Company Information

13.5.2 Elan Corporation GABA Receptor Agonist Drug Product Offered

13.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Elan Corporation Main Business Overview

13.5.5 Elan Corporation Latest Developments

13.6 Eli Lilly and Company

13.6.1 Eli Lilly and Company Company Information

13.6.2 Eli Lilly and Company GABA Receptor Agonist Drug Product Offered

13.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly and Company Main Business Overview

13.6.5 Eli Lilly and Company Latest Developments

13.7 H.LundBeck, Merck and Co

13.7.1 H.LundBeck, Merck and Co Company Information

13.7.2 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Offered

13.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 H.LundBeck, Merck and Co Main Business Overview

13.7.5 H.LundBeck, Merck and Co Latest Developments

13.8 GlaxoSmithKline

13.8.1 GlaxoSmithKline Company Information

13.8.2 GlaxoSmithKline GABA Receptor Agonist Drug Product Offered

13.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 GlaxoSmithKline Main Business Overview

13.8.5 GlaxoSmithKline Latest Developments

13.9 NovaDel Pharma

13.9.1 NovaDel Pharma Company Information

13.9.2 NovaDel Pharma GABA Receptor Agonist Drug Product Offered

13.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 NovaDel Pharma Main Business Overview

13.9.5 NovaDel Pharma Latest Developments

13.10 Novartis

13.10.1 Novartis Company Information

13.10.2 Novartis GABA Receptor Agonist Drug Product Offered

13.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis Main Business Overview

13.10.5 Novartis Latest Developments

13.11 OVATION Pharmaceuticals

13.11.1 OVATION Pharmaceuticals Company Information

13.11.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Offered

13.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 OVATION Pharmaceuticals Main Business Overview

13.11.5 OVATION Pharmaceuticals Latest Developments

13.12 Osmotica Pharmaceutical

13.12.1 Osmotica Pharmaceutical Company Information

13.12.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Offered

13.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Osmotica Pharmaceutical Main Business Overview

13.12.5 Osmotica Pharmaceutical Latest Developments

13.13 Pfizer

13.13.1 Pfizer Company Information

13.13.2 Pfizer GABA Receptor Agonist Drug Product Offered

13.13.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Pfizer Main Business Overview

13.13.5 Pfizer Latest Developments

13.14 sanofi-aventis

13.14.1 sanofi-aventis Company Information

13.14.2 sanofi-aventis GABA Receptor Agonist Drug Product Offered

13.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 sanofi-aventis Main Business Overview

13.14.5 sanofi-aventis Latest Developments

13.15 VIVUS

13.15.1 VIVUS Company Information

13.15.2 VIVUS GABA Receptor Agonist Drug Product Offered

13.15.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 VIVUS Main Business Overview

13.15.5 VIVUS Latest Developments

13.16 XenoPort

13.16.1 XenoPort Company Information

13.16.2 XenoPort GABA Receptor Agonist Drug Product Offered

13.16.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 XenoPort Main Business Overview

13.16.5 XenoPort Latest Developments

14 Research Findings and Conclusion

Table 1. GABA Receptor Agonist Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. GABA Receptor Agonist Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Bamaluzole

Table 4. Major Players of Phenibut

Table 5. Major Players of Baclofen

Table 6. Major Players of Gaboxadol

Table 7. Major Players of Klonopin (clonazepam)

Table 8. Major Players of Tiagbine

Table 9. Global GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)

Table 10. Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)

Table 11. Global GABA Receptor Agonist Drug Revenue by Type (2017-2022) & ($ million)

Table 12. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2022)

Table 13. Global GABA Receptor Agonist Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)

Table 15. Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)

Table 16. Global GABA Receptor Agonist Drug Revenue by Application (2017-2022)

Table 17. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2017-2022)

Table 18. Global GABA Receptor Agonist Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global GABA Receptor Agonist Drug Sales by Company (2020-2022) & (K Pcs)

Table 20. Global GABA Receptor Agonist Drug Sales Market Share by Company (2020-2022)

Table 21. Global GABA Receptor Agonist Drug Revenue by Company (2020-2022) ($ Millions)

Table 22. Global GABA Receptor Agonist Drug Revenue Market Share by Company (2020-2022)

Table 23. Global GABA Receptor Agonist Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers GABA Receptor Agonist Drug Producing Area Distribution and Sales Area

Table 25. Players GABA Receptor Agonist Drug Products Offered

Table 26. GABA Receptor Agonist Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global GABA Receptor Agonist Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global GABA Receptor Agonist Drug Sales Market Share Geographic Region (2017-2022)

Table 31. Global GABA Receptor Agonist Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global GABA Receptor Agonist Drug Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global GABA Receptor Agonist Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global GABA Receptor Agonist Drug Sales Market Share by Country/Region (2017-2022)

Table 35. Global GABA Receptor Agonist Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global GABA Receptor Agonist Drug Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)

Table 39. Americas GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)

Table 41. Americas GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)

Table 43. Americas GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)

Table 45. APAC GABA Receptor Agonist Drug Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)

Table 47. APAC GABA Receptor Agonist Drug Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC GABA Receptor Agonist Drug Revenue Market Share by Region (2017-2022)

Table 49. APAC GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)

Table 51. APAC GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)

Table 53. Europe GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)

Table 55. Europe GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)

Table 57. Europe GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)

Table 59. Europe GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of GABA Receptor Agonist Drug

Table 70. Key Market Challenges & Risks of GABA Receptor Agonist Drug

Table 71. Key Industry Trends of GABA Receptor Agonist Drug

Table 72. GABA Receptor Agonist Drug Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. GABA Receptor Agonist Drug Distributors List

Table 75. GABA Receptor Agonist Drug Customer List

Table 76. Global GABA Receptor Agonist Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global GABA Receptor Agonist Drug Sales Market Forecast by Region

Table 78. Global GABA Receptor Agonist Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC GABA Receptor Agonist Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC GABA Receptor Agonist Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global GABA Receptor Agonist Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Type (2023-2028)

Table 90. Global GABA Receptor Agonist Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global GABA Receptor Agonist Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Application (2023-2028)

Table 94. Global GABA Receptor Agonist Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Application (2023-2028)

Table 96. Advicenne Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 97. Advicenne GABA Receptor Agonist Drug Product Offered

Table 98. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Advicenne Main Business

Table 100. Advicenne Latest Developments

Table 101. AstraZeneca Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 102. AstraZeneca GABA Receptor Agonist Drug Product Offered

Table 103. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. AstraZeneca Main Business

Table 105. AstraZeneca Latest Developments

Table 106. Athena Drug Delivery Solutions Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Offered

Table 108. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Athena Drug Delivery Solutions Main Business

Table 110. Athena Drug Delivery Solutions Latest Developments

Table 111. Biocodex Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 112. Biocodex GABA Receptor Agonist Drug Product Offered

Table 113. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Biocodex Main Business

Table 115. Biocodex Latest Developments

Table 116. Elan Corporation Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 117. Elan Corporation GABA Receptor Agonist Drug Product Offered

Table 118. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Elan Corporation Main Business

Table 120. Elan Corporation Latest Developments

Table 121. Eli Lilly and Company Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 122. Eli Lilly and Company GABA Receptor Agonist Drug Product Offered

Table 123. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Eli Lilly and Company Main Business

Table 125. Eli Lilly and Company Latest Developments

Table 126. H.LundBeck, Merck and Co Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 127. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Offered

Table 128. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. H.LundBeck, Merck and Co Main Business

Table 130. H.LundBeck, Merck and Co Latest Developments

Table 131. GlaxoSmithKline Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 132. GlaxoSmithKline GABA Receptor Agonist Drug Product Offered

Table 133. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. GlaxoSmithKline Main Business

Table 135. GlaxoSmithKline Latest Developments

Table 136. NovaDel Pharma Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 137. NovaDel Pharma GABA Receptor Agonist Drug Product Offered

Table 138. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. NovaDel Pharma Main Business

Table 140. NovaDel Pharma Latest Developments

Table 141. Novartis Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 142. Novartis GABA Receptor Agonist Drug Product Offered

Table 143. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Novartis Main Business

Table 145. Novartis Latest Developments

Table 146. OVATION Pharmaceuticals Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 147. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Offered

Table 148. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 149. OVATION Pharmaceuticals Main Business

Table 150. OVATION Pharmaceuticals Latest Developments

Table 151. Osmotica Pharmaceutical Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 152. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Offered

Table 153. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 154. Osmotica Pharmaceutical Main Business

Table 155. Osmotica Pharmaceutical Latest Developments

Table 156. Pfizer Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 157. Pfizer GABA Receptor Agonist Drug Product Offered

Table 158. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 159. Pfizer Main Business

Table 160. Pfizer Latest Developments

Table 161. sanofi-aventis Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 162. sanofi-aventis GABA Receptor Agonist Drug Product Offered

Table 163. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 164. sanofi-aventis Main Business

Table 165. sanofi-aventis Latest Developments

Table 166. VIVUS Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 167. VIVUS GABA Receptor Agonist Drug Product Offered

Table 168. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 169. VIVUS Main Business

Table 170. VIVUS Latest Developments

Table 171. XenoPort Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors

Table 172. XenoPort GABA Receptor Agonist Drug Product Offered

Table 173. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 174. XenoPort Main Business

Table 175. XenoPort Latest Developments

List of Figures

Figure 1. Picture of GABA Receptor Agonist Drug

Figure 2. GABA Receptor Agonist Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global GABA Receptor Agonist Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global GABA Receptor Agonist Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. GABA Receptor Agonist Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Bamaluzole

Figure 10. Product Picture of Phenibut

Figure 11. Product Picture of Baclofen

Figure 12. Product Picture of Gaboxadol

Figure 13. Product Picture of Klonopin (clonazepam)

Figure 14. Product Picture of Tiagbine

Figure 15. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2021

Figure 16. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2022)

Figure 17. GABA Receptor Agonist Drug Consumed in Attention Deficit Hyperactivity Disorder (ADHD)

Figure 18. Global GABA Receptor Agonist Drug Market: Attention Deficit Hyperactivity Disorder (ADHD) (2017-2022) & (K Pcs)

Figure 19. GABA Receptor Agonist Drug Consumed in Psychiatric Disorders and Depression

Figure 20. Global GABA Receptor Agonist Drug Market: Psychiatric Disorders and Depression (2017-2022) & (K Pcs)

Figure 21. GABA Receptor Agonist Drug Consumed in Alzheimer

Figure 22. Global GABA Receptor Agonist Drug Market: Alzheimer (2017-2022) & (K Pcs)

Figure 23. GABA Receptor Agonist Drug Consumed in Epilepsy and Seizure

Figure 24. Global GABA Receptor Agonist Drug Market: Epilepsy and Seizure (2017-2022) & (K Pcs)

Figure 25. GABA Receptor Agonist Drug Consumed in Anxiety and Sleep Disorders

Figure 26. Global GABA Receptor Agonist Drug Market: Anxiety and Sleep Disorders (2017-2022) & (K Pcs)

Figure 27. GABA Receptor Agonist Drug Consumed in Obesity and Alcoholism

Figure 28. Global GABA Receptor Agonist Drug Market: Obesity and Alcoholism (2017-2022) & (K Pcs)

Figure 29. Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)

Figure 30. Global GABA Receptor Agonist Drug Revenue Market Share by Application in 2021

Figure 31. GABA Receptor Agonist Drug Revenue Market by Company in 2021 ($ Million)

Figure 32. Global GABA Receptor Agonist Drug Revenue Market Share by Company in 2021

Figure 33. Global GABA Receptor Agonist Drug Sales Market Share by Geographic Region (2017-2022)

Figure 34. Global GABA Receptor Agonist Drug Revenue Market Share by Geographic Region in 2021

Figure 35. Global GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)

Figure 36. Global GABA Receptor Agonist Drug Revenue Market Share by Country/Region in 2021

Figure 37. Americas GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)

Figure 38. Americas GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)

Figure 39. APAC GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)

Figure 40. APAC GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)

Figure 41. Europe GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)

Figure 42. Europe GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)

Figure 43. Middle East & Africa GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)

Figure 44. Middle East & Africa GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)

Figure 45. Americas GABA Receptor Agonist Drug Sales Market Share by Country in 2021

Figure 46. Americas GABA Receptor Agonist Drug Revenue Market Share by Country in 2021

Figure 47. United States GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Canada GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Mexico GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Brazil GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. APAC GABA Receptor Agonist Drug Sales Market Share by Region in 2021

Figure 52. APAC GABA Receptor Agonist Drug Revenue Market Share by Regions in 2021

Figure 53. China GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Japan GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. South Korea GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Southeast Asia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. India GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Australia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Europe GABA Receptor Agonist Drug Sales Market Share by Country in 2021

Figure 60. Europe GABA Receptor Agonist Drug Revenue Market Share by Country in 2021

Figure 61. Germany GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. France GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. UK GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Italy GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Russia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Country in 2021

Figure 67. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Country in 2021

Figure 68. Egypt GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 69. South Africa GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 70. Israel GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 71. Turkey GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 72. GCC Country GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)

Figure 73. Manufacturing Cost Structure Analysis of GABA Receptor Agonist Drug in 2021

Figure 74. Manufacturing Process Analysis of GABA Receptor Agonist Drug

Figure 75. Industry Chain Structure of GABA Receptor Agonist Drug

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles